440 related articles for article (PubMed ID: 27042108)
1. Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.
Song X; Zhang GM; Ma XC; Luo L; Li B; Chai DY; Sun LJ
Onco Targets Ther; 2016; 9():1399-407. PubMed ID: 27042108
[TBL] [Abstract][Full Text] [Related]
2. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
Luo Z; Jiao B; Huang T; Zhao H; Zhang G
Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
[No Abstract] [Full Text] [Related]
3. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.
Wang Y; Zhang H; Yang Y; Zhang T; Ma X
Front Oncol; 2019; 9():995. PubMed ID: 31649874
[No Abstract] [Full Text] [Related]
5. A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.
Altan M; Haberal HB; Akdoğan B; Özen H
Int J Clin Oncol; 2017 Oct; 22(5):964-971. PubMed ID: 28600686
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy.
Lei Y; Jiao D; Yao Z; Wang L; Zhao Z
Arch Esp Urol; 2022 Apr; 75(3):287-294. PubMed ID: 35435163
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.
Zhao X; Zhou Y; Liu B; Shen Y; Qian J; Zhang X; Zhao H
Med Sci Monit; 2023 Mar; 29():e939442. PubMed ID: 36992543
[TBL] [Abstract][Full Text] [Related]
8. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.
Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z
Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643
[TBL] [Abstract][Full Text] [Related]
9. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
Zhang GM; Zhu Y; Luo L; Wan FN; Zhu YP; Sun LJ; Ye DW
Tumour Biol; 2015 Nov; 36(11):8537-43. PubMed ID: 26032095
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma.
Cheng Y; Mo F; Pu L; Li Q; Ma X
Front Oncol; 2019; 9():955. PubMed ID: 31608240
[No Abstract] [Full Text] [Related]
12. Preoperative Low Lymphocyte-to-Monocyte Ratio Predicts Poor Clinical Outcomes for Patients with Urothelial Carcinoma of the Upper Urinary Tract.
Zhang XK; Yang P; Zhang ZL; Hu WM; Cao Y
Urol J; 2018 Nov; 15(6):348-354. PubMed ID: 30033515
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma.
Kwon BS; Jeong DH; Byun JM; Lee TH; Choi KU; Song YJ; Suh DS; Kim KH
J Cancer; 2018; 9(7):1127-1134. PubMed ID: 29675093
[No Abstract] [Full Text] [Related]
15. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
18. Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.
Yang L; Fu M; Yu L; Wang H; Chen X; Sun H
Front Endocrinol (Lausanne); 2024; 15():1293842. PubMed ID: 38370351
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Medulloblastoma: Prognostic Value of Preoperative Blood Cell Ratios.
Alimohammadi E; Bagheri SR; Arast A; Hadidi H; Safari-Faramani R
Int J Hematol Oncol Stem Cell Res; 2022 Jul; 16(3):131-139. PubMed ID: 36694701
[No Abstract] [Full Text] [Related]
20. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W
J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
